Canada markets open in 8 hours 58 minutes

Nuvo Pharmaceuticals Inc. (MRVFF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.97000.0000 (0.00%)
At close: 10:16AM EST
Full screen
Loading interactive chart...
  • Business Wire

    Miravo Healthcare™ Announces Filing of Special Meeting Materials in respect of Arrangement with Searchlight Pharma Inc.

    MISSISSAUGA, Ontario, February 07, 2023--Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare (TSX:MRV; OTCQX:MRVFF) ("Miravo" or the "Company") announced today that it has filed and is in the process of mailing the management information circular (the "Circular") and related materials in connection with the special meeting (the "Meeting") of its shareholders (the "Shareholders") to be held virtually on March 7, 2023. The Meeting has been called for Shareholders to consider and, if deemed advisable

  • Business Wire

    Miravo Healthcare™ Enters into Definitive Agreement to be Acquired by Searchlight Pharma Inc.

    MISSISSAUGA, Ontario & MONTREAL, Quebec, December 23, 2022--Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare (TSX:MRV; OTCQX:MRVFF) ("Miravo" or the "Company") and Searchlight Pharma Inc., a private Canadian-based specialty healthcare company ("Searchlight" or the "Purchaser"), are pleased to announce that they have entered into a definitive agreement (the "Arrangement Agreement") pursuant to which the Purchaser has agreed to acquire all of the issued and outstanding common shares of the Compan

  • Business Wire

    Miravo Healthcare™ Announces Third Quarter 2022 Results

    MISSISSAUGA, Ontario, November 14, 2022--Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced its financial and operational results for the three and nine months ended September 30, 2022. For further details on the results, please refer to Miravo’s Management, Discussion and Analysis (MD&A) and Condensed Consolidated Interim Fina